Tumor-stroma ratio as a new prognosticator for pseudomyxoma peritonei: a comprehensive clinicopathological and immunohistochemical study

BACKGROUND: As a rare clinical tumor syndrome with an indolent clinical course and lack of pathognomonic symptoms, pseudomyxoma peritonei (PMP) is usually diagnosed at an advanced stage. In-depth pathological analysis is essential to assess tumor biological behaviors, assist treatment decision, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ru, Lin, Yu-Lin, Li, Xin-Bao, Yan, Feng-Cai, Xu, Hong-Bin, Peng, Zheng, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667412/
https://www.ncbi.nlm.nih.gov/pubmed/34895284
http://dx.doi.org/10.1186/s13000-021-01177-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667412/
https://www.ncbi.nlm.nih.gov/pubmed/34895284
http://dx.doi.org/10.1186/s13000-021-01177-1

Ejemplares similares